Clinical trial for Covid vaccine for children near completion: Centre to HC

Centre on Friday told Delhi High Court that clinical trials for Covid-19 vaccines for children under 18 years of age are going on and on the verge of completion

Topics
Coronavirus Vaccine | Delhi High Court | clinical trials

Press Trust of India  |  New Delhi 

The Centre on Friday told the that for COVID-19 vaccines for under 18 years of age are going on and on the verge of completion.

A policy will be formed by the government and will be vaccinated when experts give permission, the Centre said.

A bench of Chief Justice D N Patel and Justice Jyoti Singh observed, Let the trials be done, otherwise it would be a disaster if vaccines are administered without trials that too in case of

Once trials are over, you quickly apply to children. The whole country is waiting, it added.

The court listed the matter for further hearing on September 6.

The high court was hearing a PIL filed on behalf of a minor. It sought directions for the immediate vaccination of those in the 12-17 age group on the ground that there were fears a likely third wave of COVID-19 could affect them more.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Fri, July 16 2021. 14:04 IST
RECOMMENDED FOR YOU